COSA is the national oncology community bringing together multidisciplinary health professionals across all cancers to advance care and improve outcomes.
As a COSA member, you will have opportunities to connect with oncology leaders, build networks and collaborations, access professional development and education, drive advocacy, and facilitate research.
COSA membership is open to healthcare professionals who have an interest in oncology relevant to the vision and mission of COSA. You are eligible for COSA membership if you hold a professional qualification, are working in healthcare or research, and devote a majority of your professional activity to cancer care and/or research.
Members of COSA Affiliated or Associated organisations are eligible for a discounted membership rate on selected individual membership types.
Membership is valid from 1 July to 30 June each year. Membership fees are GST inclusive. We accept Visa and Mastercard for payment.
If you are unsure which member type is right for you, please contact us.
Forgotten to renew?
It's not too late
Login to renew
Individual
Memberships
Medical Member
This membership is for qualified clinical practitioners with a specific interest in oncology. Medical members hold a postgraduate degree or fellowship from a recognised College or Society, eg medical or radiation oncologists, surgeons, general practitioners etc.
- $295 / year
- $265 / year (Affiliated/Associated Medical Member rate)
Allied Health Member
This membership is for health professionals or non-medical professionals with a specific interest in cancer care, eg exercise physiologists, physiotherapists, pharmacists, psychologists, nutritionist/dietitians, radiation therapists, non-clinical administrative staff etc.
- $165 / year
- $145 / year (Affiliated/Associated Allied Health Member rate)
Nursing Member
This membership is for registered nurses with a specific interest in oncology, eg breast care nurses, clinical nurse consultants, nurse practitioners etc.
- $165 / year
- $145 / year (Affiliated/Associated Nursing Member rate)
Advanced Trainee Member
This membership is for doctors in specialty training with a specific interest in cancer care, who are eligible for this membership rate for the duration of their training, eg trainees in medical, radiation and surgical oncology.
- $165 / year
- $145 / year (Affiliated/Associated Advanced Trainee Member rate)
Student Member
A person who is undertaking undergraduate or postgraduate studies with a focus on cancer care in an Australian educational institution is eligible as a student member. Students must indicate an expected completion date on application and COSA may request documented evidence of student enrolment periodically.
- $50 / year
Retiree Member
A person who has retired from professional employment, has held COSA membership for 10 years prior to retirement, and has a continued personal interest in cancer care is eligible as a retiree member, subject to Board approval.
Please contact COSA [email protected] to enquire about Retiree Membership.
- $80 / year
Honorary Member
A person who has made significant and sustained contributions to COSA or to cancer care in general is eligible for admission as an Honorary Member. This membership category is offered to past Presidents of COSA and nominees and must be approved by the COSA Board.
Affiliated and Associated
Organisations
Interested in organisational membership?
Affiliated and Associated Organisations include not-for-profit companies, institutions or organisations that have a similar vision to COSA.
If your organisation is interested in becoming an Affiliated or Associated member of COSA visit the Member Organisations page for more information.
Member OrganisationsJoin Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 5 days ago
Cancer Survivorship 2025 will showcase innovation in survivorship care, research, advocacy and policy. Health professionals and public are encouraged to attend. Earlybird registration closes this Friday 17 January. View the program and register at https://t.co/QMq00LQGmK #Surv25 https://t.co/BilfOCyd2m
Read More >COSAoncology one month ago
RT @oncodaily: Disability and cancer care – We can do both! - @ShonaEdwards2 @CVSAinfo @COSAoncology https://t.co/baqGDwRe8W #Cancer #Ca…
Read More >COSAoncology one month ago
RT @AYAGlobalCancer: Great to see how research has expanded in #AYA psychosocial care 🙌🏻 Dr Ursula Sansom-Daly @usansomdaly presents the up…
Read More >COSAoncology one month ago
Read the latest news from COSA and COSA members in our November eNewsletter. Check your inbox or login to your COSA member account to view now: https://t.co/5ib5Nlou8I https://t.co/ApABAA7WHN
Read More >COSAoncology one month ago
Congratulations David Thomas for recognition of your leadership and groundbreaking work in genomics in cancer care. And congratulations to all the recipients of the 2024 Premier's Awards for Outstanding Cancer Research. #cancerNSWawards
Read More >COSAoncology one month ago
Congratulations Ashfaq Chauhan for recognition of your work to enhance cancer care for people from CALD backgrounds.
Read More >COSAoncology one month ago
Congratulations @DrNicolasHart for recognition of your work to improve outcomes of all people affected by cancer.
Read More >COSAoncology one month ago
Congratulations @yapml for recognition of your important work in equity and cancer care.
Read More >COSAoncology 2 months ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 in Melbourne, 6-7 March. We particularly welcome submissions from survivors themselves and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/vjp4hfcVXN
Read More >COSAoncology 2 months ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 to be held in Melbourne, March 2025. We particularly welcome submissions from survivors and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/87PUAMTxwA
Read More >